November 5, 2024
Shareholder’s Letter
November 17, 2023
Investisseur.tv: Interview with Bruno Lafont, Co-funder and COO of NFL Biosciences
October 12, 2023
La Bourse et la Vie TV: Interview with Ignacio Faus, CEO of NFL Biosciences
October 12, 2023
Presentation given by the management team during the Bourse Direct webinar
June 16, 2021
Investor Presentation: IPO on Euronext Growth Paris June 2021 (french)
April 14, 2025
Annual Report 2024 (french)
September 27, 2024
2024 Half-year Report (french)
March 29, 2024
Annual Report 2023 (french)
October 6, 2023
Half Year Report 2023 (french)
April 28, 2023
Annual Report 2022 (french)
October 26, 2022
Half Year Report 2022 (french)
April 29, 2022
Annual Report 2021 (french)
October 4, 2021
Half Year Report 2021 (french)
June 16, 2021
Information document pre-IPO on Euronext Growth Paris (french)